About the Journal

Aims and Scope

Med Cancer is an international peer-reviewed & open-access medical journal published by Qingres Ltd, London, U.K. The goal of the journal is to promote advances in the field of oncology, including tumor etiology and epidemiology, molecular genetics, tumor genomics, tumor proteomics, tumor pathology, tumor diagnosis, and treatment of new technologies, new drug research, clinical diagnosis and treatment of cancer, tumor individual treatment and comprehensive treatment.

Editorial Board

  • Amancio Carnero

    Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Seville

  • Alfio Ferlito

    Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine

  • Charles Rosser

    University of Hawaii Cancer Center

  • Ken He Young

    University of Texas MD Anderson Cancer Center

  • William Cho

    Queen Elizabeth Hospital (Hong Kong)

  • Xiaohong Li

    Key Laboratory of Advanced Technologies of Materials, Ministry of Education, School of Materials Science & Engineering, Southwest Jiaotong University

Contact information for the Editorial Office

Med Cancer

Editorial Office

16 St Martin's le Grand, London, EC1A 4EN

Tel. +44 (0) 20 7397 8300

E-mail: mc@qingres.com



Indexing and Abstracting

The articles published in Med Cancer are listed in major on-line abstracting and indexing databases, including:

1. Google Scholar

2. China National Knowledge Infrastructure (CNKI)

Business Model

Article Processing Charges: click here

Advertising Policy: click here

All Rights Reserved © 2018 Qingres Co., Ltd.

Powered by Qingres Ltd.